...
首页> 外文期刊>Tumour biology : >Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion
【24h】

Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion

机译:SiSo细胞表达的可溶性受体结合癌抗原和癌胚抗原在鉴别恶性胸腔积液中的诊断价值

获取原文
获取原文并翻译 | 示例

摘要

Diagnosis of malignant pleural effusion (MPE) remains a major clinical challenge. The aim of this study was to evaluate the diagnostic value of combined detection of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) and carcinoembryonic antigen (CEA) in patients with MPE and benign pleural effusion (BPE). The serum and pleural fluid samples were collected from 53 patients diagnosed with MPE and 49 patients with BPE. Enzyme-linked immunosorbent assay was used to detect the concentration of RCAS1 in serum and pleural effusion. The clinical data and laboratory information, including CEA levels, were gathered from these cases. The concentration of RCAS1 in MPE was significantly higher than that of BPE (P < 0.001). There was no significant difference between the two serum groups. The diagnostic sensitivity and specificity of pleural fluid RCAS1 were 67.92 and 81.63 %, respectively, at the optimized cutoff value of 7.326 U/mL; meanwhile, the sensitivity and specificity of pleural fluid CEA were 83.02 and 91.84 % at the cutoff value of 3.93 ng/mL. The specificity could be elevated to 98.50 % in serial detection, while the sensitivity may be improved to 94.55 % in parallel detection. Serum RCAS1 concentration was only detected in 53 serum samples out of the 102 samples, indicating that serum RCAS1 may not be a better option in differential diagnosis of malignancies compared with serum CEA, of which the diagnostic sensitivity and specificity were 64.15 and 83.67 % at the cutoff value of 3.90 ng/mL. No significant differences were found in pleural fluid RCAS1 concentration in MPE patients with different ages, gender, and pathological types of lung cancers. The detection of RCAS1 concentration in pleural fluid is informative for the diagnosis of MPE. Joint detection of RCAS1 and CEA can improve the diagnostic sensitivity and specificity. However, the diagnostic value of RCAS1 is not higher than that of CEA.
机译:恶性胸腔积液(MPE)的诊断仍然是主要的临床挑战。这项研究的目的是评估联合检测SiSo细胞(RCAS1)和癌胚抗原(CEA)上表达的受体结合癌抗原对MPE和良性胸腔积液(BPE)患者的诊断价值。从53名诊断为MPE的患者和49名BPE患者中收集血清和胸水样本。酶联免疫吸附法用于检测血清和胸腔积液中RCAS1的浓度。从这些病例中收集了临床数据和实验室信息,包括CEA水平。 MPE中RCAS1的浓度显着高于BPE(P <0.001)。两组血清之间无显着差异。在最佳临界值7.326 U / mL下,胸水RCAS1的诊断敏感性和特异性分别为67.92和81.63%。同时,在3.93 ng / mL的临界值下,胸水CEA的敏感性和特异性分别为83.02和91.84%。连续检测的特异性可以提高到98.50%,而平行检测的灵敏度可以提高到94.55%。仅在102份样本中的53份血清样本中检测到了血清RCAS1浓度,表明与血清CEA相比,血清RCAS1可能不是恶性肿瘤鉴别诊断的更好选择,其诊断敏感性和特异性分别为64.15和83.67%。临界值为3.90 ng / mL。在不同年龄,性别和病理类型的肺癌的MPE患者中,胸水RCAS1浓度没有发现显着差异。胸水中RCAS1浓度的检测对MPE的诊断具有参考意义。联合检测RCAS1和CEA可以提高诊断的敏感性和特异性。但是,RCAS1的诊断值不高于CEA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号